ABLYX | VIVIX | ABLYX / VIVIX | |
Total Expense Ratio | 0.73 | 0.04 | 1,825% |
Annual Report Gross Expense Ratio | 0.73 | 0.04 | 1,825% |
Fund Existence | 16 years | 27 years | - |
Gain YTD | 2.889 | 1.255 | 230% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100000 | 5000000 | 2% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.2B | 189B | 2% |
Annual Yield % from dividends | 1.65 | 2.29 | 72% |
Returns for 1 year | -1.27 | 6.80 | -19% |
Returns for 3 years | 1.48 | 18.51 | 8% |
Returns for 5 years | 17.05 | 58.67 | 29% |
Returns for 10 years | -1.89 | 102.87 | -2% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RVPIX | 8.45 | 0.14 | +1.68% |
Royce Smaller-Companies Growth Instl | |||
VADCX | 67.47 | N/A | N/A |
Invesco Equally-Wtd S&P 500 C | |||
FSOAX | 39.92 | N/A | N/A |
Fidelity Advisor Value Strategies A | |||
JFCAX | 35.26 | N/A | N/A |
JHancock Fundamental All Cap Core A | |||
MSRFX | 16.39 | N/A | N/A |
Morgan Stanley Inst Next Gen Em Mkts R6 |